Skip to main content
ABCL logo

ABCL · AbCellera Biologics Inc. · Analyst Estimates

Track ABCL — free
$10.57 -0.48 (-4.34%)
Market Cap
$3.39B
Shares
306.61M

Analyst Estimates

Analyst consensus published through AbCellera Biologics Inc.'s investor-relations sources. Coverage varies by company.

Values retain the original units, accounting basis and forecast-period labels.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1703057 CUSIP 00288U106 13F (30d) 85 filings 85 filers Visit website Investor relations